Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
AZD6738 (Ceralasertib) - Chemietek
Ceralasertib | AZD6738 | ATR kinase inhibitor | antitumor | TargetMol
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a ...
(PDF) ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as ...
Ceralasertib | AZD6738 | ATR 激酶抑制剂 | 抗肿瘤 | TargetMol
AZD6738 – 美仑生物
azd6738
AZD6738 in combination with FTD decreases Chk1 phosphorylation. HT29 ...
Combination treatment of AZD6738 with 5-FU effectively suppresses tumor ...
Combination therapy with TAS-102 and AZD6738 effectively inhibits tumor ...
AZD6738 an ATR inhibitor in combination with belotecan demonstrate ...
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In ...
Ceralasertib (AZD6738) | ATR Inhibitor | MedChemExpress
Ceralasertib (AZD6738) | ≥99%(HPLC) | Selleck | ATM/ATR 阻害剤
Phase II study of ceralasertib (AZD6738) in combination with durvalumab ...
Ceralasertib (AZD6738) | ATR Inhibitor | CAS 1352226-88-0 | Selleck ...
COA of Ceralasertib (AZD6738) | Certificate of Analysis | AbMole BioScience
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination ...
Ceralasertib (AZD6738) | CAS 1352226-88-0 | AbMole BioScience ...
Clin Cancer Res：Ceralasertib(AZD6738)联合紫杉醇或可有效治疗PD1/L1耐药性黑色素瘤-MedSci.cn
(S)-Ceralasertib | (S)-AZD6738 | ATM/ATRCAS号1352226-87-9 共5条产品 – 960化工网
Ceralasertib,AZD6738 ATR抑制剂（CAS#1352226-88-0 目录号D916941） - DKM活性分子
Ceralasertib (AZD6738) | ATR抑制剂 | MCE
阿斯利康S-Ceralasertib（AZD6738）的合成策略 - 知乎
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair ...
(PDF) Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in ...
Ann Oncol：Ceralasertib (AZD6738)联合durvalumab（德瓦鲁单抗）治疗抗PD-1失败晚期/转移性黑色素瘤 ...
Ceralasertib (AZD6738) | ATM/ATR 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
Clinical Activity and Safety of the Oral ATR Inhibitor Ceralasertib ...
(PDF) Olaparib and Ceralasertib (AZD6738) in Patients with Triple ...
(PDF) Phase II study of ceralasertib (AZD6738) in combination with ...
Ceralasertib (AZD6738): 靶向ATR激酶的选择性抑制剂 - DKM活性化合物，活性分子平台
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative ...
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib ...
Dose-Dependent Bioavailability and Tissue Distribution of the ATR ...
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
ATM/ATR inhibitors: 30+Potent, Highly Selective & Cited | Selleckchem
Ceralasertib « New Drug Approvals
Ceralasertib | C20H24N6O2S | CID 121596701 - PubChem
ATR Inhibitors, ATM Inhibitors
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan ...
ASTRAZENECA « New Drug Approvals
AZD6738, an ATR inhibitor, in combination with belotecan demonstrates ...
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality ...
Ceralasertib | ATM/ATR | TargetMol
Tumor microenvironment associated with response to ceralasertib in ...
